chemotherapy

The expansion of mucus-degraders in the mouse gut—possibly due to poor nutrition—thins the colon’s mucus layer and may weaken defenses against blood-infecting microbes.

A look at some noteworthy scientists who died this year, leaving behind a legacy of research excellence.

The discovery could one day lead to the development of better antinausea medications.

Dormant cancer cells and dysfunctional immune cells living together in a tumor niche form a therapy-resistant reservoir.

Data from mouse models for mild coronavirus infections and human tissue samples offer further evidence that it doesn’t take a severe infection—or even infection of brain cells at all—to cause long-term neurological symptoms.

Tracking human cancers in mice shows some unexpected cell changes that could undermine translational research.  

A new platform enables screening a wide range of combination anticancer therapeutics in a matter of days, which may translate to personalized therapeutic regimens for patients in less time.

An unusual drug screen takes advantage of “porcupine-like” structures of cancer cells in 3D organoids.

Researchers turned white blood cells called neutrophils into drug-smuggling “neutrobots,” which penetrated the blood-brain barrier to treat brain cancer in mice.

The newly minted Baylor College of Medicine faculty member is working to crack the mystery of triple negative breast cancer.

A cancer patient who underwent the new fertility preservation procedure successfully gave birth five years after her immature eggs were collected.

Three-dimensional tissue cultures grown from cancer patients’ own tumors can predict responses to the drug irinotecan.

A prototype in-vein device would collect toxic medications before they reach healthy tissues.

Researchers have developed a prototype device to filter excess chemotherapy medication from the bloodstream.

Mustard gas blistered men’s bodies on the battlefield, but paved the way for cancer-fighting drugs.